Ronald W. McClurg - 21 Apr 2023 Form 4 Insider Report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Role: Chief Financial Officer
Signature: /s/ Stephanie Swan, by Power of Attorney
Issuer symbol: NMTC
Transactions as of: 21 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 25 Apr 2023, 15:39:59 UTC
Previous filing: 06 Feb 2023
Next filing: 14 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NMTC	Common Stock	Award	$0	+12,500	+19%	$0.000000	79,500	21 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NMTC	Option to Purchase Common Stock	Award	$0	+12,500		$0.000000	12,500	21 Apr 2023	Common Stock	12,500	$1.59	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments on the last day of each quarter over the next 8 quarters, subject to continued service on such vesting date.
F2	25% will vest on April 21, 2024 and the remaining 75% will vest in 12 equal quarterly installments on the last day of each quarter beginning on June 30, 2024.